Genmark Diagnostics (NQ: GNMK )
12.95 USD +0.53 (+4.27%) Official Closing Price Updated: 3:35 PM EST, Nov 27, 2020 Add to My Watchlist
Press releases about Genmark Diagnostics
GenMark Diagnostics to Participate in the Canaccord Virtual MedTech & Diagnostics Forum
November 05, 2020
GenMark Diagnostics Reports Third Quarter 2020 Results
October 28, 2020
GenMark Diagnostics to Report Third Quarter 2020 Financial Results on October 28, 2020
October 14, 2020
Thinking about trading options or stock in GenMark Diagnostics, General Electric, Gilead Sciences, American Airlines, or Penn National Gaming?
October 09, 2020
GenMark Diagnostics’ ePlex® Respiratory Pathogen Panel 2 (RP2) Receives EUA from FDA
October 08, 2020
Combination test for COVID-19, flu and other common respiratory illnesses helps health care professionals prepare for flu season
Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments
September 22, 2020
Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced the appointment of...
GenMark Diagnostics Announces Submission of Emergency Use Authorization for its eSensor® SARS-CoV-2 Test
August 17, 2020
GenMark Diagnostics Reports Second Quarter 2020 Results
August 04, 2020
Biodesix, Inc. a leader in lung cancer diagnostics, today announced the appointment of Jean Franchi and Hany Massarany to the company’s board of directors. Ms. Franchi has more than 30 years of...
GenMark Diagnostics Provides Preliminary Financial and Operational Results for Second Quarter 2020
July 07, 2020
GenMark Diagnostics Announces Commercial Launch of its ePlex® Respiratory Pathogen Panel 2 (RP2)
June 29, 2020
Updated test provides rapid results for SARS-CoV-2 and other important respiratory pathogens and a simplified workflow
GenMark Diagnostics Chosen as Primary Provider of Rapid Diagnostic Testing for Vidant Health
June 16, 2020
Largest health system in eastern North Carolina turns to ePlex® platform for fast results on SARS-CoV-2, respiratory and blood stream infections
GenMark Diagnostics Announces Closing of $80 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 11, 2020
Thinking about buying stock in GenMark Diagnostics, BioSig Technologies, Norwegian Cruise Line, J C Penney, or Delphi Technologies?
May 07, 2020
GenMark Diagnostics Provides Preliminary Financial and Operational Results for First Quarter 2020 and Increases 2020 Revenue Guidance
April 07, 2020
Thinking about buying stock in EXACT Sciences, GenMark Diagnostics, SunLink Health Systems, Tyson Foods, or Slack Technologies?
March 20, 2020